IMA Q3 2022 Earnings — ImageneBio Inc Revenue & Financial Results | Market Cap Arena

IMAImageneBio Inc

$69M

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M+70.9% YoY

Gross Profit

-$12M-194.4% margin

Operating Income

-$18M-279.2% margin

Net Income

-$17M-270.8% margin

EPS (Diluted)

$-0.46

QoQ Revenue Growth

+1575.9%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$18M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$190M

Total Liabilities

$32M

Stockholders' Equity

$159M

Cash & Equivalents

$67M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$4M	+70.9%
Gross Profit	-$12M	-$10M	-29.3%
Operating Income	-$18M	-$15M	-23.1%
Net Income	-$17M	-$15M	-19.4%